Open AccessTHE VALUE AND DIRECTIONS OF IMPROVING THE INVESTMENT RISK MANAGEMENT PROCESS IN A PHARMACEUTICAL COMPANY
Author(s) -
Olga V. Kadyrova,
Ю. И. Севостьянов
Publication year - 2021
Publication title -
strategii biznesa
Language(s) - English
Resource type - Journals
ISSN - 2311-7184
DOI - 10.17747/2311-7184-2021-9-260-262
Subject(s) - investment (military) , risk management , risk analysis (engineering) , business , process (computing) , value (mathematics) , open ended investment company , return on investment , financial risk , actuarial science , operations management , finance , economics , computer science , production (economics) , microeconomics , machine learning , politics , political science , law , operating system
The article considers investment risk because of the influence of uncertainty on the achievement of the goals of a particular investment project. The results of the analysis of the practice of investment risk management in a particular pharmaceutical company are presented. It is concluded that the exclusion of the stage of its processing from the investment risk management process entails the loss of possible benefits due to the refusal to implement projects based on the results of risk analysis. Improving the investment risk management process is a factor in increasing the value of the company.